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Abstract 
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that causes memory loss. Most AD researches 
have focused on neurodegeneration mechanisms. Considering that neurodegenerative changes are not revers‑
ible, understanding early functional changes before neurodegeneration is critical to develop new strategies for 
early detection and treatment of AD. We found that Tg2576 mice exhibited impaired pattern separation at the early 
preclinical stage. Based on previous studies suggesting a critical role of dentate gyrus (DG) in pattern separation, we 
investigated functional changes in DG of Tg2576 mice. We found that granule cells in DG (DG‑GCs) in Tg2576 mice 
showed increased action potential firing in response to long depolarizations and reduced 4‑AP sensitive  K+‑currents 
compared to DG‑GCs in wild‑type (WT) mice. Among Kv4 family channels, Kv4.1 mRNA expression in DG was signifi‑
cantly lower in Tg2576 mice. We confirmed that Kv4.1 protein expression was reduced in Tg2576, and this reduction 
was restored by antioxidant treatment. Hyperexcitable DG and impaired pattern separation in Tg2576 mice were also 
recovered by antioxidant treatment. These results highlight the hyperexcitability of DG‑GCs as a pathophysiologic 
mechanism underlying early cognitive deficits in AD and Kv4.1 as a new target for AD pathogenesis in relation to 
increased oxidative stress.
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Introduction
Alzheimer’s disease (AD) is a progressive neurode-
generative disorder and is the most common cause of 
dementia. Considerable evidence has indicated that AD 
patients exhibit cognitive decline several years before 
clinical diagnosis [1–3]. In particular, assessment of epi-
sodic memory is the most effective method for identify-
ing at-risk individuals [3, 4]. Synaptic loss associated with 
a decline in basal synaptic transmission and a deficit in 
induction of long-term potentiation (LTP) have been 
identified as potential underlying mechanisms for AD-
associated cognitive declined [5–7]. Synaptic loss and 
deficits were shown to be mediated by amyloid β (Aβ) and 
Tau oligomers, or epigenetic alterations [7]. On the other 
hand, AD pathogenesis also exhibits a profound increase 
in hyperactive neurons [8, 9]. Aberrant network activ-
ity associated with increased seizure are also considered 
as important factors causing cognitive decline [10]. It is 
not yet fully understood how Aβ and Tau are involved in 
both synaptic depression and neuronal hyperexcitability 
or how they are related to aberrant network activity and 
cognitive decline.
Synaptic dysfunction is widely thought to be one of 
the earliest key pathogenic events in AD before frank 
neurodegeneration, and the hippocampal network is 
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particularly vulnerable in AD [11–14]. The hippocampus 
is divided into three main fields, the dentate gyrus (DG) 
and areas CA3 and CA1, and each field displays distinc-
tive anatomical, molecular, and biophysical properties 
[15, 16]. Although all three hippocampal pathways have 
been associated with learning and memory, MF-CA3 
projection specifically has been implicated in cognitive 
function, including novelty detection, pattern comple-
tion and pattern separation [17, 18]. Indeed, structural 
and functional MRI analysis of AD patients revealed dis-
ruption of the mossy fiber (MF)-CA3 pathway in patients 
with mild AD or mild cognitive impairment [19, 20]. Syn-
aptic activity in the DG/CA3 network was proposed as an 
early target of amyloid pathology that leads to impaired 
pattern separation and episodic memory loss [21]. Con-
sistently, impaired synaptic plasticity in MF-CA3 syn-
apses at an early stage in AD model mice was reported 
[22, 23]. However, it remains to be elucidated how altera-
tion of intrinsic excitability contributes to impaired DG/
CA3 network underlying AD-associated cognitive deficit.
Sparseness of DG activity is a prerequisite for orthog-
onal representation of information which is critical for 
pattern separation function [24, 25]. This hypothesis was 
supported by an experiment showing that hyperexcit-
ability of GCs in DG induced by selective degeneration of 
hilar mossy cells led to impaired pattern separation [26]. 
We have recently reported that low excitability of mature 
GCs is attributable to a high level of Kv4.1 expression, and 
knock-down of Kv4.1 in DG causes hyperexcitability and 
impaired pattern separation [27]. In the present study, we 
investigated the possible role of Kv4.1 in impaired pat-
tern separation in the early preclinical stage of AD, and 
found that GCs in Tg2576 mice showed hyperexcitability 
and reduced Kv4.1. Furthermore, hyperexcitability and 
reduced Kv4.1 in Tg2576 GCs and impaired pattern sepa-
ration in Tg2576 mice were reversed by antioxidant treat-
ment. These results highlight the hyperexcitability of GCs 
in DG as a pathophysiologic mechanism underlying early 
cognitive deficits in AD, and Kv4.1 as a new target for AD 
pathogenesis in relation to increased oxidative stress.
Results
Impaired pattern separation in Tg2576 mice
To investigate cognitive impairment in an early stage of 
AD before expressing amyloid plaque deposition and 
severe memory loss, we used 3 ~ 4  months-old Tg2576 
mice and performed contextual fear discrimination 
tests [28]. After giving a single shock once a day for first 
3 days in context A (contextual fear acquisition), gener-
alization protocol was performed on day 4 and 5 with-
out giving a shock in a similar pair of contexts (A and 
B) that had identical metal grid floors, while context B 
had a unique odor (1% acetic acid) with dimmer lighting 
(50% of A) in the sloped floor (15° angle) (Fig.  1A). We 
observed that both WT and Tg2576 groups showed com-
parable freezing responses during 5  min test in context 
A (Fig. 1Ba). Moreover, freezing levels were not different 
between context A and B in both genotypes (Fig.  1Bb, 
WT, Tg2576, two-way ANOVA, genotype:  F(1,30) = 0.24, 
p = 0.62, context:  F(1,30) = 0.15, p = 0.70, genotype × con-
text:  F(1,30) = 0.39, p = 0.54). The mice were subsequently 
trained to disambiguate these contexts by visiting both 
contexts daily for 8 days with a 2-h-interval between the 
contexts (from day 6 to day 13), always receiving a foot 
shock 180  s after being placed in context A but not in 
context B (Fig. 1A). A daily discrimination ratio was cal-
culated by freezing during the 180  s in context A over 
total freezing during the two visits (Fig. 1Ca). On day 6, 
both groups showed a low level of freezing (Additional 
file  1: Fig. S1) and could not distinguish the differences 
between two contexts (Fig.  1Ca, genotype:  F(1,24) = 3.67, 
p = 0.06, context:  F(1,24) = 0.73, p = 0.40, genotype × con-
text:  F(1,24) = 0.31, p = 0.58); thus, the discrimination ratio 
was approximately 0.5. Over subsequent training days, 
WT mice began to freeze profoundly in context A, but 
not in context B (Additional file  1: Fig. S1), resulting in 
an increase in discrimination ratio (Fig.  1Ca). However, 
Tg2576 mice showed increased freezing in both in con-
text A and B (Additional file 1: Fig. S1 and Fig. 1Cb, t-test, 
Context B, p < 0.0001, Two-way ANOVA, genotype: 
 F(1,25) = 0.25, p = 0.62, context:  F(1,25) = 19.19, p < 0.0001, 
genotype × context:  F(1,25) = 34.63, p < 0.000004), exhibit-
ing significant deficits in the acquisition of discrimination 
ability (Fig. 1Ca). To rule out the possibility that general 
memory acquisition or storage is impaired in Tg2676 
mice, the context specificity of the conditioning was 
examined using context A and context C that is distinct 
from context A. In this configuration, context C evoked 
a significantly lower level of freezing than context A in 
both genotypes (Fig. 1D, genotype:  F(1,14) = 0.16, p = 0.70, 
context:  F(1,14) = 43.78, p < 0.000012, genotype × con-
text:  F(1,11) = 0.06, p = 0.80). These results indicate that 
3 ~ 4-month-old Tg2576 mice exhibit specific impairment 
in pattern separation between similar contexts without 
deficits in memory acquisition or learning. We did not 
perform other behavioral tests, but it was reported that 
motor functions and anxiety levels were normal in aged 
Tg2576 mice [29].
Hyperexcitability and reduced  K+ currents in Tg2576 GCs 
in DG
To investigate the possibility that the abnormal excit-
ability of granule cells (GCs) in dentate gyrus (DG) 
is involved in the impairments of pattern separation 
in Tg2576 mice, we examined intrinsic properties of 
GCs. To avoid the neural progenitor cells and newborn 






























































































































Fig. 1 Impaired pattern separation in Tg2576 mice. A Experimental procedure for pattern separation in 10‑week‑old WT and Tg2576 mice. Ba On 
day 4 to 5, the kinetics of freezing across the 5 min test in context A. Bb Percentage of freezing in context A (filled bar) and context B (open bar) 
during day 4–5. WT (blue, n = 8) and Tg2576 (green, n = 9) mice displayed equal amounts of freezing in both contexts A and B. Ca On day 6 to 
13, time course of the discrimination ratio in WT (blue, n = 8) and Tg2576 (green, n = 7) mice. Statistical significance for each day was tested using 
ANOVA (*P < 0.05; **P < 0.01; *** P < 0.001). Cb Percentage of freezing in context A (filled bar) and context B (open bar) for WT (blue, n = 8) and 
Tg2576 (green, n = 7) mice on day 11. Freezing levels were compared between the two contexts for each group (N.S., no statistical significance; 
*P < 0.05). Da Experimental procedure for one‑trial contextual fear conditioning between WT (n = 8) and Tg2576 (n = 7) mice. Db The percentage of 
freezing in context A (filled bar) and context C (open bar, distinct object) for WT (n = 8) and Tg2576 (n = 7) mice
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immature neurons, we identified mature DG granule 
neurons in the hippocampus according to their mor-
phological and electrophysiological criteria: low rest-
ing membrane potential (RMP) and input resistance 
 (Rin; < 200 MΩ) located in the outer molecular layer [27, 
30]. We found that firing frequency evoked by depolar-
izing pulses of 1  s duration was significantly higher in 
the Tg2576 GCs (green, Fig.  2A) compared to the WT 
GCs (blue, Fig. 2A). The relationship of action potential 
(AP) frequency (F) versus injected currents (I) showed 
an upward shift in DG neurons of Tg2576 mice rela-
tive controls, indicating increased neuronal excitabil-
ity (Fig. 2Ab). In agreement with these findings, the AP 
onset time during AP trains was also significantly shorter 
in Tg2576 GCs (Fig.  2B; 34.7 ± 1.3  ms, n = 13, for WT 
and 24.6 ± 1.6 ms, n = 12, for Tg2576 at 300 pA current 
injection, p = 0.000045). However, we did not find signifi-
cant differences between Tg2576 and WT mice in pas-
sive electrical properties, such as RMP,  Rin and threshold 
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Fig. 2 Electrophysiological analysis for the excitability of WT and Tg2576 mice. Aa Representative traces in the current‑clamp recording from the 
WT (blue) and Tg2576 (green) dentate GCs in response to prolonged (1 s) depolarizing current injection (200 pA). Ab Number of spike evoked 
during 1 s current injections with varying amplitudes (from 100 to 600 pA, 100 pA increment). At all amplitudes, the number of spikes is significantly 
higher in Tg2576 GCs (green closed circle, n = 14) compared to WT GCs (blue closed circle, n = 15). Mean ± S.E.M. **P < 0.01; *** P < 0.001 B 
Expanded view of overlaid 1st APs evoked by 300 pA current injection to show the shortening of AP onset in Tg2576 GCs compared to WT GCs. 
Mean ± S.E.M. *** P < 0.001 C The mean values of the resting membrane potential (WT: − 84.5 ± 1.3 mV, Tg2576: − 81.8 ± 1.0 mV), input resistance 
(WT: 161.6 ± 6.9 MΩ, Tg2576: 158.8 ± 9.5 MΩ), and rheobase (WT: 181.1 ± 6.7 pA, Tg2576: 173.5 ± 7.7) from the WT (n = 15) and Tg2576 GCs (n = 14). 
Mean ± S.E.M. N.S., not significantly different. Da Representative traces of current‑clamp recordings from CA1 of WT (blue) and Tg2576 mice (green). 
A train of APs were evoked by 1 s depolarizing current pulse injection (100 pA). Db The F‑I curve for CA1 from WT (n = 4) and Tg2576 (n = 4) mice
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p = 0.11641,  Rin: p = 0.8121, Rheobase: p = 0.46504). 
However, unlike DG GCs, the excitability of CA1 pyrami-
dal neurons was not different between Tg2576 and WT 
mice (Fig.  2D), suggesting the GC-specific hyperexcit-
ability in Tg2576 mice. These results suggest that the 
enhanced excitability of GCs in Tg2576 mice is unlikely 
to be attributable to the alteration of  Na+ channels or 
ion channels in determining the subthreshold membrane 
excitability. We therefore hypothesized that downregula-
tion of Kv4.1 channels that play key roles in low excitabil-
ity of mature GCs [27] may cause the hyperexcitability of 
Tg2576 GCs.
To examine this hypothesis, we first recorded  K+ cur-
rents in the voltage clamp mode by applying depolariz-
ing voltage steps (ranging from − 60 mV to + 30 mV with 
10  mV increment and 1  s duration) at a holding poten-
tial of -70 mV. TTX,  Cd2+/Ni2+, bicuculline, and CNQX 
were added to the external solution to block  Na+ chan-
nels,  Ca2+ channels,  GABAA receptors, and AMPA/
kainate receptors, respectively. We found that total out-
ward  K+ currents in Tg2576 GCs are similar to that in 
WT GCs (Fig. 3A), while  K+ currents sensitive to 5 mM 
4-AP  (I4-AP) are substantially less in Tg2576 GCs relative 
to WT GCs (Fig. 3B). The difference was found both in 
the peak current  (Ipeak) (at + 30  mV; WT: 2.234 ± 0.203 
nA, n = 9, Tg2576; 1.624 ± 0.197 nA, n = 7, p = 0.0477) 
and in the steady state current  (Iss) (at + 30  mV; WT: 
0.505 ± 0.042 nA, n = 9, Tg2576: 0.161 ± 0.037 nA, n = 7, 
p = 0.000197). Notably, reduction of  Iss was greater than 
 Ipeak in Tg2576, suggesting that reduced  I4-AP in Tg2576 
GCs is attributable to downregulation of  K+ channels 
that inactivate slowly. We further analyzed the difference 
in  I4-AP between WT and Tg2576 GCs (Fig. 3C). To fur-
ther analyze inactivation of  I4-AP, we fitted inactivation 
phases of  I4-AP with a two-exponential decay function, 
I(t) =  Afast exp(− t/τfast) +  Aslow exp(− t/τslow). The results 
showed that the amplitude of the slow component  (Aslow) 
was selectively reduced in the Tg2576 GCs compared to 
WT GCs, whereas the other parameters  (Afast, τfast, and 
τslow) were not altered (Fig.  3C). Considering that the 
slowly inactivating component of  I4-AP in GCs was mainly 
attributable to Kv4.1 current [27], these results suggest 
that reduced  I4-AP in Tg2576 GCs is attributable to the 
decrease in Kv4.1 current.
Kv4.1 downregulation is responsible for hyperexcitability 
of Tg2576 GCs
To investigate the molecular identity of the decreased 
 I4-AP in Tg2576 GCs, we examined whether mRNA 
expression levels of Kv4 family channels are altered using 
quantitative Real-Time PCR (qRT-PCR) techniques. We 
found that the Kv4.1 mRNA expression level in DG was 
significantly lower in Tg2576, while Kv4.2 and Kv4.3 
mRNA expressions levels were not altered (Fig.  4A; 
Kv4.1: p = 0.000058, Kv4.2: p = 1, Kv4.3: p = 0.62857, 
Mann–Whitney test). These results suggest that Kv4.1 
expression was selectively downregulated in Tg2576 
without compensation by the other Kv4 channel subu-
nits. In agreement with these findings, Kv4.1 protein 
level in DG was also significantly lower in Tg2576 com-
pared to WT (Fig.  4B). To examine the functionality of 
reduced Kv4.1 expression in Tg2576, we examined the 
effects of Kv4.1 antibody perfusion via a whole-cell patch 
pipette on firing frequency. In WT GCs, action potential 
firing evoked by depolarizing pulses of 1 s duration was 
increased significantly by Kv4.1 antibody (from 7.6 ± 0.9 
to 14.2 ± 3.2, n = 5, p = 0.00718, Fig. 4C), which is consist-
ent with our previous results in GCs of C57BL/6 control 
mice [27]. These results confirmed that Kv4.1 contributes 
to lowering firing frequency in GCs in WT as in C57BL/6 
mice. In contrast, firing frequency was not significantly 
affected by Kv4.1 antibody in Tg2576 GCs (15.2 ± 1.9 vs 
17.3 ± 2.9, p = 0.64891, Fig. 4C). It was also noted that fir-
ing frequency of WT GCs with Kv4.1 antibody was com-
parable with that of Tg2576 GCs (p = 0.79502, Fig.  4C). 
These results support the idea that Kv4.1 is responsible 
for limiting AP firing in WT GCs, and that reduced Kv4.1 
in Tg2576 GCs is a key mechanism for enhanced excit-
ability in Tg2576 GCs.
Hyperexcitability of Tg2576 GCs and impaired pattern 
separation in Tg2576 mice are restored by antioxidant 
treatment
We previously reported that mitochondrial reac-
tive oxygen species (ROS) production is increased 
in Tg2576 DG at the age of 1- to 2-months, causing 
depolarization of mitochondrial membrane potential 
and impairment of  Ca2+ uptake int mitochondria. Fur-
thermore, this impairment is restored by treatment of 
antioxidant, Trolox [31]. We have recently reported 
that calbindin, a major  Ca2+ buffer in dentate GCs, is 
crucial for Kv4.1 activity, and that calbindin knockout 
mice also show hyperexcitable DG, reduced  K+ cur-
rents, and impaired pattern separation [32]. Interest-
ingly,  Ca2+ buffer capacity of Tg2576 GCs is as low 
as that in calbindin knockout mice, and it is restored 
by Trolox [32], suggesting that calbindin is a target of 
oxidative stress. We therefore addressed the question 
whether ROS overproduction underlies hyperexcit-
ability in Tg2576 GCs due to Kv4.1 downregulation. To 
this end, we first examined the effects of Trolox on the 
hyperexcitability phenotype in the Tg2576 GCs. Prein-
cubation of Tg2576 GCs in the aCSF containing Trolox 
(500  μM) for 1  h did not affect the relationship of AP 
frequency and injected currents (orange, Fig.  5A), 
while injection of Trolox (20 mg/Kg) into Tg2576 mice 
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intraperitoneally (i.p.) once a day for 1 week induced 
a downward shift in the relationship of AP frequency 
and injected currents (purple, Fig.  5A). AP frequency 
in Tg2576 GCs following Trolox treatment for 1 week is 
similar to that in WT GCs (dashed blue line, Fig. 5Ab). 
Consistently, Western blot analysis for Kv4.1 proteins 
showed a significant increase in Tg2576 mice after 
1 week treatment of treated with Trolox (Fig. 5B). These 
results suggest that restoration of excitability and Kv4.1 
expression by Trolox treatment is not a rapid process. 
We finally examined whether Trolox treatment restored 
impaired pattern separation in Tg2576 mice. Contex-
tual fear discrimination tests described in Fig.  1 were 
performed in Tg2576 mice treated with Trolox for 
1 week. Freezing levels during 5  min test at day 4–5 
showed comparable freezing levels with those observed 
in Tg2576 mice (Fig.  5C), while deficits in contextual 
Ba Bb5 mM 4-AP sensitive current
WT Tg2576 Ipeak
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1 s
-60 to +30 mV-70 mV
1 s
-60 to +30 mV-70 mV
1 s
-60 to +30 mV-70 mV
Fig. 3 Voltage‑dependent  K+ currents in the WT and Tg2576. Aa Superimposed current traces evoked by various steps of depolarization (− 60 mV 
to + 30 mV in 10 mV step) for 1 s from the holding potential of − 70 mV in the WT (blue) and Tg2576 (green) dentate GCs. Ab Amplitudes of peak 
currents  (Ipeak) and steady state currents  (Iss) measured at the end of depolarization are plotted as a function of the given potential (V). WT (closed 
blue circle, n = 9) and Tg2576 (closed green circle, n = 7). Ba The difference in currents before and after applying 5 mM 4‑AP  (I4‑AP) in the WT (blue) 
and Tg2576 (green) dentate GCs. Bb  Ipeak and  Iss for  I4‑AP are plotted as a function of the given potential (V). WT (closed blue circle, n = 9) and Tg2576 
(closed green circle, n = 7). Ca  I4‑AP traces obtained at + 30 mV are averaged (WT, blue, n = 9; Tg2576, green, n = 7) and superimposed. Cb I4‑AP 
recorded at + 30 mV were fitted to double‑exponential functions. Amplitude and time constant for the fast component  (Afast, τfast) and the slow 
component  (Aslow, τslow). Mean ± S.E.M., **, P < 0.01, ***, P < 0.001.  N.S. not significantly different, P > 0.05
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fear discrimination observed in Tg2576 mice (green, 
Fig.  5D) was restored by Trolox treatment (purple, 
Fig.  5D). These results support the idea that impaired 
pattern separation in the early preclinical stage of AD is 
attributable to the hyperexcitability of GCs mediated by 
ROS-induced downregulation of Kv4.1.
Discussion
AD is characterized as a neurodegenerative disease, 
although functional deficits occurred prior to neuro-
degeneration. We reported in our previous study that 
impaired post-tetanic potentiation was observed at the 
preclinical stage of AD [22]. It was demonstrated that 
mitochondrial dysfunctions such as increased ROS pro-
duction, partial depolarization of mitochondrial poten-
tial, and impaired  Ca2+ uptake occurred in dentate GCs 
of 1 ~ 2-month-old Tg2576 mice, leading to the deficits 
in mitochondria-dependent short-term plasticity at the 
mossy fiber-CA3 synapses. The observation that anti-
oxidant treatment can restore the reduced short-term 
plasticity and impaired mitochondrial  Ca2+ uptake in 
Tg2576 mice suggests that the increased ROS production 
in mitochondria initiates the other dysfunctions. In the 
present study, we revealed that hyperexcitability of GCs 
caused by Kv4.1 downregulation occurs in the early stage 
of AD. Furthermore, we showed that impaired pattern 
separation, possibly an early symptom of cognitive defi-
cit, is linked to hyperexcitability of GCs and that both can 
be restored by antioxidant treatment. Our study suggests 
that ion channel remodeling induced by oxidative stress 
may underlie cognitive deficit in early AD pathogenesis.
Elevated excitability in the hippocampus has emerged 
as a key contributor to cognitive impairment in AD, 
though some studies reported reduced intrinsic excit-
ability associated with AD [33, 34]. Hyperexcitability 
including increased firing rate and an elevated number 
of activated neurons associated with AD was reported 
in CA1 [35–37] and CA3 pyramidal neurons [38, 39]. 
Tight coupling between excitability and cognitive pheno-
type was also recognized in aging [40]. Reducing hyper-
excitability with the antiepileptic drug levetiracetam 
restores cognitive deficits in AD as well as in mild cog-
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Fig. 4 Downregulation of Kv4.1 expression in Tg2576 causes hyperexcitability of Tg2576 GCs. A mRNA expression levels for Kv4 family channels in 
the WT (blue) and Tg2576 (green) DG detected by quantitative RT‑PCR. B Western blot analysis for Kv4.1 in DG of 8‑week‑old mice. For a loading 
control, β‑actin was used. Right, Kv4.1expression in Tg2576 was significantly smaller than WT mice. *, P < 0.05. Ca Example traces of APs evoked by 
200 pA current injection immediate (3 min, blue for WT and green for Tg2576) and 15 min (red) after brake‑in of patch pipettes containing Kv4.1 
antibody. Cb Firing frequency at 200 pA is compared in each conditions
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of hyperexcitability in AD pathogenesis. However, ion 
channel mechanisms underlying hyperexcitability were 
not identified in most studies. Kv4.2 was suggested to be 
involved in altered excitability in pathologic condition, 
yet the role is not conclusive. Kv4.2 current was reduced 
by intracellular accumulation of Aβ42 [37] or Tau [44], 
while an aging-related increase in A-type potassium 
currents was attributed to increased firing frequency by 
facilitating repolarization [39]. In the present study, we 
not only demonstrated hyperexcitability of GCs in AD 
model mice, but also identified Kv4.1 downregulation 
in GCs as underlying mechanism of hyperexcitability. 
Causal relationship between decreased Kv4.1 expression, 
hyperexcitability of GCs, and impaired pattern separa-
tion in Tg2576 mice is strongly supported by our previ-
ous study [27].
Among many complex factors underlying AD patho-
genesis, network abnormality caused by neuronal hyper-
activity has recently emerged as a potential mechanism 
of cognitive dysfunction [10, 45–47] and epileptic seizure 
[46, 48–50]. A causal link between Aβ accumulation and 
network abnormalities and epileptogenesis was proposed 
[46, 50]. Functional magnetic resonance imaging (fMRI) 
of humans with early symptomatic AD has demon-
strated excessive neuronal activities in the hippocampus 
and neocortex, where Aβ accumulates in abundance [9]. 
Since neuronal hyperactivity increases extracellular Aβ 
levels [51], it may initiate a vicious cycle that facilitates 
progressive pathology and memory impairment [52]. The 
molecular basis of this hyperexcitability has been exam-
ined, and Aβ-induced hyperexcitability of layer 2/3 (L2/3) 
pyramidal neurons [45], the dysfunction of parvalbumin-
positive interneurons in L2/3 parietal cortex [53], and 
impaired glutamate reuptake by neurons and astrocytes 
[50] have been proposed so far. Considering that DG 
functions as a “gate” controlling information flow from 
the entorhinal cortex into the rest of the hippocampus, 
and hyperexcitability of dentate GCs has long been 
known as one of epileptogenic mechanisms underlying 
temporal lobe epilepsy [54, 55], hyperexcitability of GCs 
caused by downregulation of Kv4.1 may contribute to 
network abnormalities associated with increased seizure 
as well as cognitive impairment associated in AD. Impor-
tance of DG in AD pathogenesis has been recently high-
lighted in studies showing restoration of memory in AD 
mice by optogenetic activation of DG engram cells [56, 
57]. DG manipulation may be a potential target for treat-
ing cognitive deficit and memory loss in AD.
Kv4.1 belongs to the Kv4 gene subfamily together with 
Kv4.2 and Kv4.3 [58–60]. Based on electrophysiological 
and pharmacological properties, Kv4 channels are known 
to mediate A-type  K+ currents  (IA), which are character-
ized by their rapid inactivation kinetics and their sensi-
tivity to 4-aminopyridine (4-AP) blockade. However, a 
recent study showed that Kv4.1 in the hippocampus has 
unique electrophysiological characteristics and expres-
sion patterns distinctive from those of Kv4.2 [27]. Kv4.2 
was shown to mediate  IA in CA1 pyramidal neurons, 
regulating AP repolarization phase [61–63], while Kv4.1 
was weakly expressed and had no role in CA1 pyrami-
dal neurons [27]. Interesingly, Kv4.1 expression was sig-
nificant in DG, and Kv4.1-mediated currents detected 
only in low-frequency firing mature GCs displayed slow 
inactivation kinetics [27]. Inhibition of Kv4.1 currents 
by shRNA or antibody induced a significant increase in 
firing frequency [27], suggesting that Kv4.1 played a key 
role in lowering firing frequency in mature GCs. Fur-
thermore, specific knockdown of Kv4.1 in the DG region 
selectively impaired conditional freezing between similar 
contexts, suggesting that low frequency firing of mature 
GCs is crucial for pattern separation [27]. The present 
study highlights Kv4.1 as a target ion channel that causes 
hyperexcitability of DG in AD, leading to impaired pat-
tern separation.
Fig. 5 Effect of pre‑treatment with Trolox in the Tg2576 mice. Aa Representative trace in the current‑clamp recording of pre‑treatment with Trolox 
for one hour (orange) and 1 week (purple) in Tg2576 in response to depolarizing current injection (200 pA with 1 s duration). Ab F‑I curve (from 
100 to 600 pA, 100 pA increment) obtained from GCs of Tg2576 mice treated with Trolox for 1 week (Tg + Trolox, purple, n = 8) was compared with 
the F‑I curve obtained from Tg2576 GCs (green dashed line, n = 14) shown in Fig. 2Ab. *, P < 0.05, ***, P < 0.001. B Western blot analysis for Kv4.1 in 
DG of 8‑week‑old Tg2576 mice and those treated with Trolox (20 mg/kg) for 1 week. For a loading control, β‑actin was used. Right, Kv4.1expression 
in Tg2576 was significantly increased after Trolox treatment. **, P < 0.01. Ca On day 4–5, the kinetics of freezing across the 5 min test in context A 
obtained from Tg2576 mice treated with Trolox for 1 week (Tg + Trolox, purple, n = 10) was compared with the that obtained from control Tg2576 
GCs (green, n = 7) shown in Fig. 1Ba. Cb Percentage of freezing in context A (filled bar) and context B (open bar) during day 4 to 5. Tg2567 (green, 
n = 7) and Tg + Trolox (purple, n = 10) mice displayed equal amounts of freezing in both contexts A and B. Da On day 6 to 12, time course of the 
discrimination ratio in Tg + Trolox mice (purple, n = 10) was compared with that obtained from control Tg2576 mice shown in Fig. 1Ca (green, n = 7) 
mice. Statistical significance for each day was tested using unpaired t‑test (*P < 0.05; **P < 0.01; ***P < 0.001). Db Percentage of freezing in context 
A (filled bar) and context B (open bar) for Tg2576 (green, n = 7) and Tg + Trolox (purple, n = 10) mice on day 11. Freezing levels were compared 
between the two contexts for each group. Tg2567 (green, n = 7) mice displayed equal amounts of freezing in both contexts A and B, while and 
Tg + Trolox (purple, n = 10) mice displayed more freezing in context A compared to context B
(See figure on next page.)
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Our previous study suggested that dentate GCs may be 
the earliest target for AD-associated oxidative stress [22]. 
The present study implies that overproduction of ROS is 
responsible for the reduction of Kv4.1 expression in the 
young Tg2576 mice. The molecular mechanism how oxi-
dative stress involved in AD pathology decreases Kv4.1 
expression remains to be investigated. ROS-dependent 
regulation of channel expression is little understood in 
neurons, whereas a few studies in non-neuronal cells 
showed that ROS exerts diverse effects on expression and 
activity of  Na+,  K+ and  Ca2+ channels [64–66]. Mito-
chondria are not only the major source of ROS but also 
the primary target of ROS, which induces cellular dys-
function. Overproduction of ROS in Tg2576 mice is cor-
related with mitochondrial Aβ accumulation, probably 
leading to mitochondrial depolarization and the reduc-
tion in respiratory enzyme activities and oxygen con-
sumption [22, 67, 68]. The treatment of Trolox on GCs of 
Tg2576 mice restored the mitochondrial function in par-
allel with the reduction of ROS in GCs [22]. Intriguingly, 
a recent study suggested that the setpoint of neuronal 
excitability may be regulated by mitochondrial oxygen 
consumption capacity [69]. It remains to be elucidated 
whether mitochondria are involved in ROS-mediated 
downregulation of Kv4.1 in Tg2576 mice.
Materials and methods
Behavior analysis
All experiments procedures were conducted in accord-
ance with the guide lines of University Committee on 
Animal Resource in Seoul National University (Approval 
No. SNU-090115-7). Male Tg2576 transgenic mice 
and their littermate wild-type control (WT) mice aged 
10-weeks were trained to discriminate between two 
similar contexts, A and B, through repeated experience 
in each context. Context A (conditioning context) was a 
chamber (18  cm wide × 18  cm long × 30  cm high; H10-
11 M-TC; Coulbourn Instruments 5583, PA 18052, USA) 
consisting of a metal grid floor, aluminum side walls, 
and a clear Plexiglass front door and back wall. Context 
A was indirectly illuminated with a 12 W light bulb. The 
features of Context B (safe context) were the same as 
Context A, except for a unique scent (1% acetic acid), 
dimmer light (50% of A), and a sloped floor by 15° angle. 
Each context was cleaned with 70% ethanol before the 
animals were placed. On the first 3 days (contextual fear 
acquisition), mice were placed in Context A for 3  min 
for exploring the environment, and then received a sin-
gle foot shock (0.75  mA, for 2  s). Mice were returned 
to their home cage 1  min after the shock. On day 4–5, 
mice of each genotype were divided into two groups; one 
group visited Context A on Day 4 and Context B on Day 
5, while the other group visited the Context B on Day 4 
and Context A on Day 5. On day 4–5 (generalization), 
neither group received a shock in Context A and B, and 
freezing level was measured for 5  min only in Context 
A. We defined freezing behavior as behavioral immobil-
ity except for respiration movement. We observed video 
image for 2-s bouts every 10  s (18 or 30 observation 
bouts for 3 min or 5 min recording time) and counted the 
number of 2-s bouts during which the mouse displayed 
freezing behavior (referred to as the freezing score). The 
percentage of freezing was calculated by dividing the 
freezing score with the total number of observation bouts 
(18 or 30). Mice were subsequently trained to discrimi-
nate these two contexts by visiting the two contexts daily 
for 8 days (from day 6 to 13, discrimination task). Mice 
always received a foot shock (2 s) 3 min after being placed 
in Context A but not B. Discrimination ratios were cal-
culated according to  FA /  (FA +  FB), where  FA and  FB are 
freezing scores in Contexts A and B, respectively. To test 
context specificity, mice were exposed to Context A and 
C for 5 min each on Day 1. On Day 2, mice were placed 
in Context A for 3  min followed by a foot shock (2  s), 
and returned to their home cage 1 min after the shock. 
Freezing behavior was observed on the next day (Day 3) 
in either Context A or C for 3 min. All experiments and 
analyses were performed blind to the mice genotype.
Preparation of brain slices
Brain slices were prepared from male Tg2576 transgenic 
mice and their littermate wild-type control (WT) mice 
aged from 1 to 2  months old. Average ages of WT and 
Tg2576 used in the present study were 5.7 week (n = 75) 
and 5.8 week (n = 53), respectively. Experiments for den-
tate GCs were mostly conducted using mice at postnatal 
week (PW) 4 to PW 7, while experiments for CA1-PCs 
were conducted using mice at PW 3 to PW 4. For in-
vivo antioxidant pretreatment experiments, age-matched 
male Tg2576 mice were assigned to receive 6-Hydroxy-
2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox, 
Sigma-Aldrich, St. Louis, MO) by intraperitoneal injec-
tion for 1  week. Trolox dosage was adopted from Bet-
ters et al. (2004), in which a 20 mg/kg priming dose was 
used to block oxidative stress [70]. Mice were killed by 
decapitation after being anesthetized with isoflurane, 
and the whole brain was immediately removed from the 
skull and chilled in artificial cerebrospinal fluid (aCSF) 
containing (in mM): 125 NaCl, 25  NaHCO3, 2.5 KCl, 
1.25  NaH2PO4, 2  CaCl2, 1  MgCl2, 20 glucose, 1.2 pyru-
vate and 0.4 Na-ascorbate, pH 7.4 when saturated with 
carbogen (95%  O2 and 5%  CO2) at 4 °C. Transverse hip-
pocampal slices (350  μm thick) were prepared using a 
vibratome (VT1200S, Leica, Germany). Slices were incu-
bated at 35  °C for 30  min and thereafter maintained at 
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32 °C until in situ slice patch recordings and fluorescence 
microscopy.
Electrophysiological analysis for excitability and  K+ 
currents
Hippocampal GCs of DG were visualized using an 
upright microscope equipped with differential interfer-
ence contrast (DIC) optics (BX51WI, Olympus, Japan). 
Electrophysiological recordings were made by the whole 
cell clamp technique with EPC-8 amplifier (HEKA, 
Lambrecht, Germany). Experiments were performed 
at 32 ± 1  °C. The perfusion rate of bathing solution and 
the volume of the recording chamber for slices were 
2.2 ml/min and 1.2 ml, respectively. Patch pipettes with 
a tip resistance of 3–4 MΩ were used. The series resist-
ance  (Rs) after establishing whole-cell configuration was 
between 10 and 15  MΩ.  Rs was monitored by applying 
a short (40  ms) hyperpolarization (5  mV) pulse during 
the recording. The pipette solution contained (in mM): 
143 K-gluconate, 7 KCl, 15 HEPES, 4 MgATP, 0.3 NaGTP, 
4 Na-ascorbate, and 0.1 EGTA with the pH adjusted to 7.3 
with KOH. For the antibody-blocking experiments, patch 
pipettes were dipped into an internal solution and then 
back-filled with the internal solution containing the anti-
body of Kv4.1 at a concentration of 0.3 µg/ml. In all bath 
solutions (aCSF), 20  μM bicuculine and 10  μM CNQX 
were included to block the synaptic inputs. In voltage 
clamp experiments to record  K+ currents, we added 
TTX (0.5  µM),  CdCl2 (300  µM) and  NiCl2 (500  µM) to 
block  Na+ and  Ca2+ channels, and membrane poten-
tials were depolarized to a maximum of 30 mV for 1 s by 
10 mV increments from the holding potential of -70 mV. 
In current clamp experiments to analyze neuronal excit-
ability, the following parameters were measured: (1) the 
resting membrane potential, (2) the input resistance  (Rin, 
membrane potential changes (V) for given hyperpolariz-
ing current (−  35 pA, 600  ms) input), (3) AP threshold 
(current threshold for single action potential genera-
tion, 100 ms duration), (4) F-I curve (firing frequency (F) 
against the amplitude of injected currents (I), for DG; 
100 pA to 600 pA, 100 pA increment, 1  s duration, for 
CA1 pyramidal cells (CA1 PCs); 50 pA to 250 pA, 50 
pA increment, 1  s duration). Membrane potentials are 
given without correction for liquid junction potentials. 
All chemicals were obtained from Sigma (St. Louis, MO, 
USA), except CNQX, bicuculline, and TTX purchase 
from abcam Biochemicals (Cambridge, UK).
RNA extraction and Quantitative real‑time PCR (qRT‑PCR)
Total RNA was isolated from mouse hippocampal DG 
region using TRIzol reagent (Invitrogen, Carlsbad, CA). 
We used 1- to 2-month-old male WT and Tg2576 mouse. 
cDNA was produced from 1  µg of total isolated RNA 
using the Invitrogen superscript III First-strand synthe-
sis system for RT-PCR (Cat.18080-051) from Invitrogen. 
The expression levels of Kv4.1, Kv4.2, Kv4.3, and GAPDH 
were determined using sequence specific primers and 
Power  SYBR® Green PCR Master Mix (Applied Biosys-
tems, Part No. 4367659) for qRT-PCR, experiments were 
conducted on a 7900HT Fast Real-Time PCR System 
(Applied Biosystems). Primers used in qRT-PCR reac-
tions as follows (5′- to -3′): GAPDH, GCA ACA GGG 
TGG TGG ACC T (forward) and GGA TAG GGC CTC TCT 
TGC TCA (reverse), Kv4.1, GCC GCA GTA CCT CAG 
TAT CATC (forward) and GAC AGA GGC AGT AGA GTT 
GGCA (reverse), Kv4.2, ATC GCC CAT CAA GTC ACA 
GTC (forward) and CCG ACA CAT TGG CAT TAG GAA 
(reverse), Kv4.3, AGA TTA CCA CGG CCA TCA TC (for-
ward) and GGA AGG AAT GTT CGT GTT GG (reverse). 
Data were analyzed using the threshold cycle relative 
quantification method, with GAPDH as the endogenous 
control. Real-time PCR was performed in duplicate using 
the same amplification protocol described above.
Western blot analysis
DG region was isolated from slices under the dissect-
ing microscope. Isolated tissues were homogenized with 
a glass homogenizer in TNE buffer (50  mM Tris–HCl, 
pH 8.0, 150 mM NaCl, and 2 mM EDTA) supplemented 
with protease inhibitor cocktails (Roche), and sonicated 
for 10 s. After adding SDS (0.5%) and Triton X-100 (1%), 
lysates were incubated for 30  min at 4  °C. Insoluble 
materials were removed by centrifugation at 20,000×g 
for 15 min at 4  °C. The amount of protein in the super-
natants were determined by the BCA assay, and super-
natants were mixed with 6 × Laemmli sample buffer. 
Samples containing 20 μg protein were loaded into each 
lane, separated by SDS-PAGE, and transferred to a PVDF 
membrane. Membranes were blocked in 5% skim milk in 
TBS for 1 h, and then probed with the relevant antibod-
ies as indicated. Membranes were then incubated with 
peroxidase-conjugated secondary antibodies, and blots 
were detected with chemiluminescent reagents (Thermo 
Scientific). Antibodies to Kv4.1 and β-actin for Western 
blot analysis were purchased from Alomone lab (APC-
119) and Cell signaling (#4970), respectively.
Statistical analysis
Data were analyzed with Igor Pro (Version 6; Wavemet-
rics, Lake Oswego, CA) and Origin (Version 8; Micro-
cal, Northampton, MA). All results are presented as 
mean ± S.E.M. with the number of cells or mice (n) 
used in each experiment. Statistical significance was 
evaluated using Student’s t-test or Mann–Whitney 
test, and the level of significance was indicated by the 
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number of marks (*, P < 0.05; **, P < 0.01; ***, P < 0.001). 
P > 0.05 was regarded as not significantly different 
(N.S.). Comparison between multifactorial statistical 
data was made using the two-way analysis of variance 
(ANOVA). Differences in time-dependent changes of 
behavioral parameters between the two genotypes were 
evaluated using two-way repeated measures ANOVA.
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